Media Availability: NIH Scientists Draw Evidence-Based Blueprint for HIV Treatment and Prevention
Tuesday, December 1, 2015
In a new commentary, NIAID’s Dr. Anthony Fauci and a colleague argue that the results of three large clinical trials definitively prove that the benefits of starting antiretroviral therapy (ART) early in infection outweigh any theoretical risk. Moreover, they write, the combination of pre-exposure prophylaxis (PrEP) and prompt initiation of ART could potentially bring about an end to the HIV/AIDS pandemic.
No hay comentarios:
Publicar un comentario